Drug Changes


Here you will find a listing of the drugs that have been changed on our drug list (formulary) for the plan year you select.

To request Medicare Part D prescription drug coverage determinations (including tiering or formulary exception requests) please use the following form:


Oxbryta Tablet 500 MG Oral


Post Date:
2/1/2025
Effective Date:
2/1/2025
Type of Change:
Drug removed
Reason Changed:
Drug discontinued from marketplace
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Hydroxyurea Capsule 500 MG Oral Tier 2 ST Antineoplastics, Other
* Please reference your Evidence of Coverage for applicable cost-sharing.

Relyvrio Packet 3-1 GM Oral


Post Date:
2/1/2025
Effective Date:
2/1/2025
Type of Change:
Drug removed
Reason Changed:
Drug discontinued from marketplace
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Riluzole Tablet 50 MG Oral Tier 2 Central Nervous System, Other
* Please reference your Evidence of Coverage for applicable cost-sharing.

Selzentry Tablet 25 MG Oral


Post Date:
2/1/2025
Effective Date:
2/1/2025
Type of Change:
Drug removed
Reason Changed:
Drug discontinued from marketplace
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Maraviroc Tablet 150 MG Oral Tier 4 Anti-HIV Agents, Other
* Please reference your Evidence of Coverage for applicable cost-sharing.

Selzentry Tablet 75 MG Oral


Post Date:
2/1/2025
Effective Date:
2/1/2025
Type of Change:
Drug removed
Reason Changed:
Drug discontinued from marketplace
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Maraviroc Tablet 150 MG Oral Tier 4 Anti-HIV Agents, Other
* Please reference your Evidence of Coverage for applicable cost-sharing.

Sprycel Tablet 100 MG Oral


Post Date:
2/1/2025
Effective Date:
2/1/2025
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Dasatinib Tablet 100 MG Oral Tier 5 PA, QL Molecular Target Inhibitors
* Please reference your Evidence of Coverage for applicable cost-sharing.

Sprycel Tablet 140 MG Oral


Post Date:
2/1/2025
Effective Date:
2/1/2025
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Dasatinib Tablet 140 MG Oral Tier 5 PA, QL Molecular Target Inhibitors
* Please reference your Evidence of Coverage for applicable cost-sharing.

Sprycel Tablet 20 MG Oral


Post Date:
2/1/2025
Effective Date:
2/1/2025
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Dasatinib Tablet 20 MG Oral Tier 5 PA, QL Molecular Target Inhibitors
* Please reference your Evidence of Coverage for applicable cost-sharing.

Sprycel Tablet 50 MG Oral


Post Date:
2/1/2025
Effective Date:
2/1/2025
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Dasatinib Tablet 50 MG Oral Tier 5 PA, QL Molecular Target Inhibitors
* Please reference your Evidence of Coverage for applicable cost-sharing.

Sprycel Tablet 70 MG Oral


Post Date:
1/31/2025
Effective Date:
2/1/2025
Type of Change:
Drug removed
Reason Changed:
Drug discontinued from marketplace
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Dasatinib Tablet 70 MG Oral Tier 5 PA, QL Molecular Target Inhibitors
* Please reference your Evidence of Coverage for applicable cost-sharing.

Sprycel Tablet 80 MG Oral


Post Date:
1/31/2025
Effective Date:
2/1/2025
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Dasatinib Tablet 80 MG Oral Tier 5 PA, QL Molecular Target Inhibitors
* Please reference your Evidence of Coverage for applicable cost-sharing.

Tazorac Cream 0.05 % External


Post Date:
1/31/2025
Effective Date:
2/1/2025
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Tazarotene Cream 0.05 % External Tier 4 Acne and Rosacea Agents
* Please reference your Evidence of Coverage for applicable cost-sharing.

Phenytoin Sodium Extended CAPSULE 200 MG ORAL


Post Date:
3/1/2025
Effective Date:
3/1/2025
Type of Change:
Drug removed - Discontinued from marketplace
Reason Changed:
Drug discontinued from marketplace
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Phenytek Capsule 200 MG Oral Tier 2 Sodium Channel Agents
* Please reference your Evidence of Coverage for applicable cost-sharing.

Phenytoin Sodium Extended CAPSULE 300 MG ORAL


Post Date:
3/1/2025
Effective Date:
3/1/2025
Type of Change:
Drug removed - Discontinued from marketplace
Reason Changed:
Drug discontinued from marketplace
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Phenytek Capsule 300 MG Oral Tier 2 Sodium Channel Agents
* Please reference your Evidence of Coverage for applicable cost-sharing.